Results 201 to 210 of about 5,381,952 (282)

Multi‐Omics Integration Identifies a Five‐Gene Metabolic Signature With Experimental Validation in Clear Cell Renal Cell Carcinoma

open access: yesCancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Clear cell renal cell carcinoma (ccRCC) is hallmarked by profound metabolic reprogramming; however, its intricate crosstalk with the tumor immune microenvironment (TIME) and its clinical ramifications remain inadequately elucidated.
Yi Peng   +4 more
wiley   +1 more source

A Review of Artificial Intelligence in Ophthalmology: Key Aspects, Challenges, and Future Directions

open access: yesEye &ENT Research, Volume 3, Issue 3, Page 125-154, September 2026.
ABSTRACT Artificial intelligence (AI) is increasingly reshaping ophthalmology because the specialty depends heavily on structured imaging, quantitative measurements, and repeatable diagnostic workflows. This review provides a clinically grounded and translationally oriented synthesis of AI in ophthalmology, covering methodological foundations ...
Partha Pratim Ray
wiley   +1 more source

Research on Wireless Communication Optimization Design for Self‐Recovering Multi‐Interface Encrypted Communication Terminals Based on OMAP Architecture

open access: yesEngineering Reports, Volume 8, Issue 9, September 2026.
This study optimizes a wireless communication terminal using an OMAP dual‐core processor and encryption chips. It achieves under 55 μs latency, ≤ 0.06% packet loss, and millisecond‐level self‐recovery in complex environments, ensuring secure and reliable communication.
Wenmin Xie   +4 more
wiley   +1 more source

Streamlining Hospital Planning: A User‐Friendly Decision Support Tool for Enhanced Healthcare Delivery

open access: yesThe International Journal of Health Planning and Management, Volume 41, Issue 5, Page 967-981, September 2026.
ABSTRACT Healthcare providers worldwide face challenges in maintaining a delicate balance between rising demand and limited resources. Decision‐makers often struggle with planning and implementing new services, leading to costly consequences and hindering efficiency, patient outcomes, and staff well‐being. Current systems lack a comprehensive modelling
Eren Demir
wiley   +1 more source

Efficacy of Interleukin‐12/23 and Interleukin‐23 Inhibitors for Moderately to Severely Active Crohn's Disease in Advanced Treatment Failure Populations: Systematic Review and Network Meta‐Analysis

open access: yesJCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background and Aims Earlier trials of advanced treatments indicated for moderately to severely active Crohn's disease used predominantly re‐randomized induction responder designs, whereas newer treatments were evaluated using treat‐through designs.
Christopher Ma   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy